Skip to content

Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage

Role of 3 Tesla Diffusion Weighted Magnetic Resonance Imaging (DW-MRI) for Diagnosis Bladder Cancer Grade and Stage. Potential Role of the Apparent Diffusion Coefficient (ADC) Value

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03138837
Enrollment
385
Registered
2017-05-03
Start date
2017-05-15
Completion date
2018-05-15
Last updated
2017-05-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Apparent Diffusion Coefficient, Bladder Cancer, Diagnoses Disease, Magnetic Resonance Imaging

Keywords

Bladder cancer, Magnetic Resonance Imaging, Bladder Cancer Superficial

Brief summary

assess diagnostic performance of 3-Tesla DW-MRI in detecting and staging bladder cancer and potential role of the ADC value as a biomarker reflecting histological grade and stage.

Interventions

DIAGNOSTIC_TESTMagnetic resonance imaging

Diffusion Weighted Magnetic resonance imaging

Sponsors

Mansoura University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Men and women 18 years or older * Suspected by the out-patient flexible cystoscopy as Non-muscle invasive bladder cancer. * Patient who will undergo radical cystectomy. * Patient with history of allergy to iodinated contrast media

Exclusion criteria

* Refuse to complete study requirements * Patient with any of the following: 1. Any metallic fragment or foreign body 2. Coronary and peripheral artery stents 3. Aortic stent graft 4. Prosthetic heart valves and annuloplasty rings 5. Cardiac pacemaker 6. Implanted cardioverter-defibrillator (ICD) 7. Retained trans venous pacemaker and defibrillator leads 8. Cochlear, otologic, or other ear implant

Design outcomes

Primary

MeasureTime frameDescription
assess the diagnostic performance of 3-T DW-MRI in detecting and staging bladder cancer1 yearcomparing the radiological diagnosis with the pathological specimen results

Countries

Egypt

Contacts

Primary ContactAbdelwahab R. Hashem, Msc
abdelwahab_hashem@yahoo.com01069678979
Backup ContactMohammed H. Zahran, MD
zahranmha@yahoo.com01063338690

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026